Reach Us +44-1477412632
Ana Isabel Jiménez | OMICS International
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
View More

Ana Isabel Jiménez


Beneficials Effects of Canagliflozin in a Weight-Centered Management in Patients with Type 2 Diabetes Mellitus in Real Practice

Objective: Evaluate the real-world efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus (T2DM), associated to a weight-loss intensive lifestyle intervention program (WLIP), to achieve weight loss greater than 5% at 12 months. Methods: Retrospective review of patients with T2DM included in a WLIP, who were prescribed canag... Read More»

Florentino Carral, Manuel Cayón, Ana Isabel Jiménez and Daniel Cabo

Research Article: Endocrinol Metab Syndr 2018, 7: 286

DOI: 10.4172/2161-1017.1000286

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Conferences